Pathological Complete Remission | List of Frontiers open access articles

Original Research

Published on 29 Nov 2022

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

in Cancer Molecular Targets and Therapeutics

Dan Que
Hongbo Zou
Bijing Mao
Huan Zhang
Wei Liang
Qin Liu
Leiyu Ke
Lijie Guo
Qichao Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.967675

5,930 views
2 citations

Original Research

Published on 07 Aug 2024

Factors associated with pathological complete remission after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a real-world clinical setting

in Gastrointestinal Cancers: Colorectal Cancer

Minglin Lin
Junsheng Liu
Chongyuan Lan
Ming Qiu
Wei Huang
Cun Liao
Sen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1421620

3,143 views
4 citations

Original Research

Published on 28 Mar 2019

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

in Women's Cancer

Elisabet Cuyàs
Maria Buxó
Maria José Ferri Iglesias
Sara Verdura
Sonia Pernas
Joan Dorca
Isabel Álvarez
Susana Martínez
Jose Manuel Pérez-Garcia
Norberto Batista-López

Frontiers in Oncology

doi 10.3389/fonc.2019.00193

8,374 views
25 citations

Case Report

Published on 04 Jul 2024

Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Xiong Liu
Maoqi Wang
Deyuan Meng
Yuntao Tang
Qingtong Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1332314

2,653 views

Case Report

Published on 13 Jan 2023

Does PD-1 blockade play a decisive role in the pathological complete remission of unresectable MSS, BRAF V600E-mutated metastatic colorectal cancer: A case report

in Gastrointestinal Cancers: Colorectal Cancer

Li Tan
Qing-Shu Li
Dong Peng
Yong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.976622

3,543 views
2 citations

Original Research

Published on 31 Mar 2023

RETRACTED: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer

in Cancer Imaging and Image-directed Interventions

Xiaoping He
Zongsheng Wang
Ying Zhou
Yongli Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1132186

3,000 views
1 citation

Case Report

Published on 09 Dec 2025

Neoadjuvant chemotherapy, DEB-TACE, and 3D-printed prosthesis for primary pelvic pleomorphic undifferentiated sarcoma: a case report

in Surgical Oncology

Jiahui Liu
Jiawen Wang
Hui Dai
Qi Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1641058

1,000 views

Case Report

Published on 29 Jan 2025

Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy

in Thoracic Oncology

Hanhan Li
Ruilian Chen
Wei Guo
Shang Xiang
Jiayang Huang
Hanrui Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1483766

1,947 views
1 citation

Case Report

Published on 02 Nov 2022

Pathological complete remission of a locally advanced gastric cancer by neoadjuvant therapy “sandwich” regimen as SOXAP+ fluorescence laparoscopic surgery +SOXAP: Case report

in Pharmacology of Anti-Cancer Drugs

Yanling Ma
Bofang Wang
Ewetse Paul Maswikiti
Xueyan Wang
Na Wang
Hao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1008755

3,593 views
2 citations

Original Research

Published on 07 May 2026

Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label, phase 2 trial (HCHTOG1906)

in Cancer Immunity and Immunotherapy

Yan Zheng
Jiwei Wu
Lingdi Zhao
Yaxing Shen
Guanghui Liang
Keting Li
Quanli Gao
Wenqun Xing

Frontiers in Immunology

doi 10.3389/fimmu.2026.1770662

202 views

Original Research

Published on 22 Jan 2020

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS

in Women's Cancer

Qiong Wang
Qun Xiang
Lan Yu
Ting Hu
Yangyang Chen
Jue Wang
Xiu Nie
Jing Cheng

Frontiers in Oncology

doi 10.3389/fonc.2019.01545

4,996 views
17 citations

Systematic Review

Published on 30 Jan 2024

Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Jincheng Wang
Ti Tong
Guangxin Zhang
Chengyan Jin
Haiping Guo
Xueying Liu
Zhengxiao Zhang
Jindong Li
Yinghao Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339757

7,765 views
13 citations

Clinical Trial

Published on 10 Jan 2024

RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03)

in Cancer Molecular Targets and Therapeutics

Feng Wen
Tianhai Lin
Peng Zhang
Yali Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1233196

7,254 views
22 citations

Original Research

Published on 02 Feb 2023

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer

in Cancer Immunity and Immunotherapy

Jiale Gao
Xiao Zhang
Zhengyang Yang
Jie Zhang
Zhigang Bai
Wei Deng
Guangyong Chen
Rui Xu
Qi Wei
Yishan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1057947

5,031 views
26 citations

Original Research

Published on 24 Jun 2024

Comparison of immunochemotherapy and chemotherapy alone in conversion therapy for locally advanced unresectable esophageal squamous cell carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhiyun Xu
Zhenbing You
Mengzhou Chen
Mingzhi Zhang
Cheng Shen
Dafu Xu
Keping Xu
Wenze Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1370353

2,473 views
7 citations

Original Research

Published on 20 Jan 2021

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer

in Women's Cancer

Zhen Wang
Lei Liu
Ying Li
Zi’an Song
Yi Jing
Ziyu Fan
Sheng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.575317

15,011 views
22 citations

Articles

Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

Factors associated with pathological complete remission after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a real-world clinical setting

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma

Does PD-1 blockade play a decisive role in the pathological complete remission of unresectable MSS, BRAF V600E-mutated metastatic colorectal cancer: A case report

RETRACTED: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer

Neoadjuvant chemotherapy, DEB-TACE, and 3D-printed prosthesis for primary pelvic pleomorphic undifferentiated sarcoma: a case report

Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy

Pathological complete remission of a locally advanced gastric cancer by neoadjuvant therapy “sandwich” regimen as SOXAP+ fluorescence laparoscopic surgery +SOXAP: Case report

Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label, phase 2 trial (HCHTOG1906)

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS

Evaluation of neoadjuvant immunotherapy in resectable gastric/gastroesophageal junction tumors: a meta-analysis and systematic review

RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03)

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer

Comparison of immunochemotherapy and chemotherapy alone in conversion therapy for locally advanced unresectable esophageal squamous cell carcinoma

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer